Increased Regulatory Scrutiny on Health Technology Companies’ Use of Advertising Technologies | Fenwick & West LLP
The proliferation of wellbeing apps and connected units that allow for people to monitor their wellbeing situations, therapy, prescription drugs, health, fertility, rest, mental wellness, diet regime and other very important parts has led to elevated regulatory scrutiny. Recent regulatory…
Holiday Rush Brings Health Plans Eagerly Awaited RxDC Reporting Guidance and Relief | Faegre Drinker Biddle & Reath LLP
In FAQs Component 56, issued on December 23, 2022, the Treasury Department and the Departments of Labor and Wellbeing and Human Products and services (collectively, Departments) issued important steering on prescription drug advantage and expense reporting expected of well being…